Clin2
NCT06502834Possibly a fitRecruiting

Testing a probiotic supplement for overweight people

ObesityMetabolic SyndromeSteatosis of Liver

Part of Digestive system, Hormones & metabolism clinical trials.

This trial studies a supplement called D. piger to see if it's safe and how it affects alcohol breakdown in overweight adults with insulin resistance. You would take the supplement daily for 4 weeks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are a man or a woman who has gone through menopause.
  • Your waist is larger than 102 cm (men) or 88 cm (women).
  • You have a condition called insulin resistance (a blood test showing HOMA above 2.5).
  • You are between 18 and 70 years old.
  • You do not take any regular prescription medicines (except occasional pain relievers like Tylenol).
  • You have not taken antibiotics or probiotic supplements in the last 3 months.
  • You have no history of heart attack or stroke, gallbladder removal, or ongoing stomach or bowel issues.
  • You are not a smoker and do not have a problem with alcohol.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07507929Not yet recruiting
Probiotics for weight loss in overweight adults

This trial tests whether a probiotic supplement can help overweight or obese adults lose weight when combined with a low-carb, reduced-calorie diet. It may be a good option if you are looking for extra support alongside dietary changes.

Luoyang, Henan
NCT06030362Recruiting
Probiotic study for weight and gut health in adults

This study tests whether taking a probiotic supplement can help with weight management and gut health in adults with overweight or obesity. You may be able to join if you are between 18 and 50, have a BMI of 25 to 40, and are generally healthy.

Los Angeles, California
NCT03418857Recruiting· Phase 1/Phase 2
Probiotics for weight- and blood-sugar–related gut health

This trial tests whether taking probiotics can improve gut health in people with early metabolic problems related to extra body fat, cholesterol, blood pressure, or blood sugar. It’s a Phase 1/2 study, meaning safety and early effectiveness are being tested.

University Park, Pennsylvania
NCT07731139Not yet recruiting· Phase 1
Testing a new medicine for people with obesity

This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.

Lake Forest, California
NCT07193927Recruiting· Phase 2
Testing a probiotic mix for fatty liver disease (MASLD)

This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.

Girona, Girona
NCT07165431Recruiting
Postbiotic supplement study for overweight and obesity

This study tests whether taking a daily postbiotic gummy for 12 weeks can improve body composition and metabolic health in people with overweight or obesity. It may help if you have stable weight and no major health conditions like diabetes.

Pamplona, Navarre

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.